Stay updated on Safety of HSC835 in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Safety of HSC835 in Hematological Malignancies Clinical Trial page.

Latest updates to the Safety of HSC835 in Hematological Malignancies Clinical Trial page
- Check6 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 on the page, reflecting a platform update.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now shows a new Revision: v3.5.3, replacing the previous v3.5.2. This indicates a minor site update.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2. This update appears to be a version patch with no impact on study details or page content.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded three disease terms—Burkitt lymphoma, B-cell chronic lymphocytic leukemia, and acute lymphoid leukemia—to the study's keywords/MeSH terms to broaden indexing and searchability.SummaryDifference0.2%

- Check63 days agoChange DetectedSite revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Safety of HSC835 in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of HSC835 in Hematological Malignancies Clinical Trial page.